Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 9/2016

22.01.2016 | Retinal Disorders

Prediction of regression of retinal neovascularisation after panretinal photocoagulation for proliferative diabetic retinopathy

verfasst von: Irini P. Chatziralli, Theodoros N. Sergentanis, Sobha Sivaprasad

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to evaluate the regression of neovascularization elsewhere (NVE) after panretinal photocoagulation (PRP) based on its location in relation to the internal limiting membrane (ILM).

Methods

Participants in this retrospective case series were 47 patients with active NVE within the vascular arcade. All patients were treated with PRP and followed up for at least 12 months. The time to regression of NVE based on its location relative to the ILM on spectral domain-optical coherence tomography (SD-OCT) was analyzed.

Results

The proportion of eyes, showing regression of NVE at the end of follow-up period was 19/25 (76 %) in the “below ILM” group and 13/22 (59 %) in the “above ILM” group. The “below ILM” group was associated with a twofold enhanced regression of NVE in comparison to the “above ILM” group (HR = 2.13, p = 0.038).

Conclusions

Regression of NVE is determined by its location relative to the ILM. Patients with “below ILM” NVE were found to show a twofold increased regression rate in comparison with the “above ILM” group, while the proportion of eyes showing regression of NVE at the end of the follow-up period was significantly greater in the “below ILM” than the “above ILM” group.
Literatur
1.
Zurück zum Zitat Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMed
2.
3.
Zurück zum Zitat Muqit MM, Stanga PE (2014) Fourier-domain optical coherence tomography evaluation of retinal and optic nerve head neovascularisation in proliferative diabetic retinopathy. Br J Ophthalmol 98:65–72CrossRefPubMed Muqit MM, Stanga PE (2014) Fourier-domain optical coherence tomography evaluation of retinal and optic nerve head neovascularisation in proliferative diabetic retinopathy. Br J Ophthalmol 98:65–72CrossRefPubMed
4.
Zurück zum Zitat Cho H, Alwassia AA, Regiatieri CV, Zhang JY, Baumal C, Waheed N, Duker JS (2013) Retinal neovascularization secondary to proliferative diabetic retinopathy characterized by spectral domain optical coherence tomography. Retina 33:542–547CrossRefPubMedPubMedCentral Cho H, Alwassia AA, Regiatieri CV, Zhang JY, Baumal C, Waheed N, Duker JS (2013) Retinal neovascularization secondary to proliferative diabetic retinopathy characterized by spectral domain optical coherence tomography. Retina 33:542–547CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Muqit MM, Stanga PE (2014) Swept-source optical coherence tomography imaging of the cortical vitreous and the vitreoretinal interface in proliferative diabetic retinopathy: assessment of vitreoschisis, neovascularisation and the internal limiting membrane. Br J Ophthalmol 98:994–997CrossRefPubMed Muqit MM, Stanga PE (2014) Swept-source optical coherence tomography imaging of the cortical vitreous and the vitreoretinal interface in proliferative diabetic retinopathy: assessment of vitreoschisis, neovascularisation and the internal limiting membrane. Br J Ophthalmol 98:994–997CrossRefPubMed
6.
Zurück zum Zitat Lee CS, Lee AY, Sim DA, Keane PA, Mehta H, Zarranz-Ventura J, Fruttiger M, Egan CA, Tufail A (2015) Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography. Am J Ophthalmol 159:101–110CrossRefPubMed Lee CS, Lee AY, Sim DA, Keane PA, Mehta H, Zarranz-Ventura J, Fruttiger M, Egan CA, Tufail A (2015) Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography. Am J Ophthalmol 159:101–110CrossRefPubMed
7.
Zurück zum Zitat Miura M, Muramatsu D, Hong YJ, Yasuno Y, Itami A, Iwasaki T, Goto H (2015) Three-dimensional vascular imaging of proliferative diabetic retinopathy by doppler optical coherence tomography. Am J Ophthalmol 159:528–538CrossRefPubMed Miura M, Muramatsu D, Hong YJ, Yasuno Y, Itami A, Iwasaki T, Goto H (2015) Three-dimensional vascular imaging of proliferative diabetic retinopathy by doppler optical coherence tomography. Am J Ophthalmol 159:528–538CrossRefPubMed
8.
Zurück zum Zitat The Diabetic Retinopathy Study Research Group (1976) Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 81:383–396CrossRef The Diabetic Retinopathy Study Research Group (1976) Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 81:383–396CrossRef
9.
Zurück zum Zitat KARNS number 1 (1993) Randomized comparison of krypton vs argon scatter photocoagulation for diabetic disc neovascularisation. Ophthalmology 100:1655–1664CrossRef KARNS number 1 (1993) Randomized comparison of krypton vs argon scatter photocoagulation for diabetic disc neovascularisation. Ophthalmology 100:1655–1664CrossRef
10.
Zurück zum Zitat Nagpal M, Marlecha S, Nagpal K (2010) Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser. Retina 30:452–458CrossRefPubMed Nagpal M, Marlecha S, Nagpal K (2010) Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser. Retina 30:452–458CrossRefPubMed
11.
Zurück zum Zitat Alasil T, Waheed NK (2014) Pan retinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser. Curr Opin Ophthalmol 25:164–170CrossRefPubMed Alasil T, Waheed NK (2014) Pan retinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser. Curr Opin Ophthalmol 25:164–170CrossRefPubMed
12.
Zurück zum Zitat Chappelow AV, Tan K, Waheed NK, Kaiser PK (2012) Panretinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser. Am J Ophthalmol 153:137–142CrossRefPubMed Chappelow AV, Tan K, Waheed NK, Kaiser PK (2012) Panretinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser. Am J Ophthalmol 153:137–142CrossRefPubMed
13.
Zurück zum Zitat Burton DS, Carrim ZI (2015) Angiographic evidence of peripheral ischemia in diabetic retinopathy and the risk of impending neovascularisation. Can J Diabetes 39:14–15CrossRefPubMed Burton DS, Carrim ZI (2015) Angiographic evidence of peripheral ischemia in diabetic retinopathy and the risk of impending neovascularisation. Can J Diabetes 39:14–15CrossRefPubMed
14.
Zurück zum Zitat Zhu Y, Zhang T, Wang KY, Xu GZ (2014) Prognostic value of multifocal electroretinography and optical coherence tomography in eyes undergoing panretinal photocoagulation for diabetic retinopathy. Invest Ophthalmol Vis Sci 55:6358–6364CrossRefPubMed Zhu Y, Zhang T, Wang KY, Xu GZ (2014) Prognostic value of multifocal electroretinography and optical coherence tomography in eyes undergoing panretinal photocoagulation for diabetic retinopathy. Invest Ophthalmol Vis Sci 55:6358–6364CrossRefPubMed
15.
Zurück zum Zitat Yang CS, Hung KC, Huang YM, Hsu WM (2013) Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy. J Ocul Pharmacol Ther 29:550–555CrossRefPubMedPubMedCentral Yang CS, Hung KC, Huang YM, Hsu WM (2013) Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy. J Ocul Pharmacol Ther 29:550–555CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Muqit MM, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Stanga PE (2013) Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy. Acta Ophthalmol 91:251–258CrossRefPubMed Muqit MM, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Stanga PE (2013) Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy. Acta Ophthalmol 91:251–258CrossRefPubMed
17.
Zurück zum Zitat Muqit MM, Young LB, McKenzie R, John B, Marcellino GR, Henson DB, Turner GS, Stanga PE (2013) Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study. Br J Ophthalmol 97:220–227CrossRefPubMed Muqit MM, Young LB, McKenzie R, John B, Marcellino GR, Henson DB, Turner GS, Stanga PE (2013) Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study. Br J Ophthalmol 97:220–227CrossRefPubMed
18.
Zurück zum Zitat The Early Treatment Diabetic Retinopathy Study Research Group (1987) Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No 3. Int Ophthalmol Clin 27:254–264CrossRef The Early Treatment Diabetic Retinopathy Study Research Group (1987) Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No 3. Int Ophthalmol Clin 27:254–264CrossRef
19.
Zurück zum Zitat Muqit MM, Marcellino GR, Henson DB, Young LB, Turner GS, Stanga PE (2011) Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4. Eye 25:1447–1456CrossRefPubMedPubMedCentral Muqit MM, Marcellino GR, Henson DB, Young LB, Turner GS, Stanga PE (2011) Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4. Eye 25:1447–1456CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Flaxel C, Bradle J, Acott T, Samples JR (2007) Retinal pigment epithelium produces matrix metalloproteinases after laser treatment. Retina 27:629–634CrossRefPubMed Flaxel C, Bradle J, Acott T, Samples JR (2007) Retinal pigment epithelium produces matrix metalloproteinases after laser treatment. Retina 27:629–634CrossRefPubMed
21.
Zurück zum Zitat Vujosevic S, Bini S, Midena G, Berton M, Pilotto E, Midena E (2013) Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT. J Diabetes Res 2013:491835PubMedPubMedCentral Vujosevic S, Bini S, Midena G, Berton M, Pilotto E, Midena E (2013) Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: an in vivo study using spectral domain OCT. J Diabetes Res 2013:491835PubMedPubMedCentral
22.
Zurück zum Zitat Zeng HY, Green WR, Tso MO (2008) Microglial activation in human diabetic retinopathy. Arch Ophthalmol 126:227–232CrossRefPubMed Zeng HY, Green WR, Tso MO (2008) Microglial activation in human diabetic retinopathy. Arch Ophthalmol 126:227–232CrossRefPubMed
23.
Zurück zum Zitat De Benedetto U, Sacconi R, Pierro L, Lattanzio R, Bandello F (2015) Optical coherence tomographic hyperreflective foci in early stages of diabetic retinopathy. Retina 35:449–453CrossRefPubMed De Benedetto U, Sacconi R, Pierro L, Lattanzio R, Bandello F (2015) Optical coherence tomographic hyperreflective foci in early stages of diabetic retinopathy. Retina 35:449–453CrossRefPubMed
24.
Zurück zum Zitat Davis MD (1965) Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol 74:741–751CrossRefPubMed Davis MD (1965) Vitreous contraction in proliferative diabetic retinopathy. Arch Ophthalmol 74:741–751CrossRefPubMed
25.
Zurück zum Zitat Ono R, Kakehashi A, Yamagami H, Sugi N, Kinoshita N, Saito T, Tamemoto H, Kuroki M, Lshikawa SE, Kawakami M (2005) Prospective assessment of proliferative diabetic retinopathy with observations of posterior vitreous detachment. Int Ophthalmol 26:15–19CrossRefPubMed Ono R, Kakehashi A, Yamagami H, Sugi N, Kinoshita N, Saito T, Tamemoto H, Kuroki M, Lshikawa SE, Kawakami M (2005) Prospective assessment of proliferative diabetic retinopathy with observations of posterior vitreous detachment. Int Ophthalmol 26:15–19CrossRefPubMed
Metadaten
Titel
Prediction of regression of retinal neovascularisation after panretinal photocoagulation for proliferative diabetic retinopathy
verfasst von
Irini P. Chatziralli
Theodoros N. Sergentanis
Sobha Sivaprasad
Publikationsdatum
22.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 9/2016
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-016-3275-4

Weitere Artikel der Ausgabe 9/2016

Graefe's Archive for Clinical and Experimental Ophthalmology 9/2016 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.